Publications by authors named "Doreen Barrett"

Claim this Profile
S
Safety and Efficacy of Apitegromab in Patients With Spinal Muscular Atrophy Types 2 and 3: The Phase 2 TOPAZ Study.
Thomas O Crawford, Basil T Darras, John W Day, Sally Dunaway Young, Tina Duong, Doreen Barrett

Neurology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular Atrophy.
Doreen Barrett, Sanela Bilic, Yung Chyung, Shaun M Cote, Ryan Iarrobino

Adv Ther· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis